The impact of Kommerell diverticulum resection on patient outcomes: A 21-year comparative analysis of surgical techniques for vascular rings

Kommerell憩室切除术对患者预后的影响:血管环手术技术21年比较分析

阅读:1

Abstract

OBJECTIVE: Kommerell diverticulum is an embryologic remnant of the dorsal fourth aortic arch. It often presents as part of vascular rings with a right dominant arch. Historically, these have been treated by dividing the ligamentum arteriosum. In recent years, some centers have adopted Kommerell diverticulum resection with subclavian translocation as a primary approach. However, no long-term studies have directly compared outcomes with simple ligamentum division. To address this, we conducted a 21-year dual-institution review comparing short- and long-term outcomes across surgical strategies. METHODS: A retrospective review of 131 patients who underwent vascular ring repair at 2 institutions was performed. Of these, 93 underwent simple ligamentum division and 38 underwent Kommerell diverticulum resection with subclavian artery translocation. Anatomic subtypes, symptoms, perioperative outcomes, and follow-up data were compared. RESULTS: There were no significant differences in intraoperative or postoperative complication rates between groups. Short-term symptoms such as dyspnea (P = .56), cough (P = .72), and dysphagia (P = .55) were comparable. Rates of recurrent laryngeal nerve injury (P = .67), chylothorax (P = .18), infection (P = .62), hospital stay (P = .49), and 30-day readmission (P = .63) were also similar. Four patients in the simple division group required reoperation; none did in the Kommerell diverticulum group (P = .32). Symptom recurrence at long-term follow-up did not differ significantly (P = .30). CONCLUSIONS: Kommerell diverticulum resection with arterial translocation is safe and effective, with favorable outcomes comparable to simple ligamentum division.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。